Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH – a double-blind randomized trial

INTRODUCTION: Currently alpha1-adrenoceptor blockers (AB) are widely used as first-line therapy to improve lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). We compared the efficacy and safety profile of tamsulosin, alfuzosin and silodosin in LUTS due to BPH. MA...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cent European J Urol
Asıl Yazarlar: Manohar, Chikka Moga Siddaiah, Nagabhushana, Mahadevappa, Karthikeyan, Vilvapathy Senguttuvan, Sanjay, Ramachandra Pudakalkatti, Kamath, Ananth Janardhan, Keshavamurthy, Ramaiah
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Polish Urological Association 2017
Konular:
Original Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510335/
https://ncbi.nlm.nih.gov/pubmed/28721281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5173/ceju.2017.924
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller